$18.35
0.885.04%
Dern. MÀJ: Oct 21, 4:49 AM
$18.29
0.824.69%
Bicara Therapeutics (BCAX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.81 | $-0.65 | $-0.68 | $-0.54 |
| Actual | $-0.82 | $-0.93 | $-0.68 | $-0.67 |
| Surprise | -1.23% | -43.1% | 0.00% | -24.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.83 | $-0.86 | $-0.91 | $-0.94 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.82 | $-0.81 | -1.23 % |
| Q1 | May 11, 2026 | $-0.93 | $-0.65 | -43.1 % |
| Q4 | Mar 30, 2026 | $-0.68 | $-0.68 | 0.00 % |
| Q3 | Nov 10, 2025 | $-0.67 | $-0.54 | -24.1 % |